Cognosos Competitive Intelligence & Landscape
cognosos.com ·
Overview
Cognosos Overview
Cognosos targets industries that benefit from real-time asset management and operational efficiency, such as healthcare institutions aiming to improve staff safety and compliance, and automotive and logistics companies seeking end-to-end visibility of parts and vehicles. The company emphasizes delivering dependable, results-oriented solutions that generate tangible ROI within months through a subscription-based model, helping clients reduce costs, increase velocity, and enhance safety (cognosos.com, tracxn.com). Its mission is centered on innovation, reliability, and customer collaboration, aiming to democratize access to advanced location intelligence technology for businesses of all sizes (cognosos.com/about-us, cognosos.com). As of 2026, Cognosos employs around 79 people and continues to expand its impact across multiple sectors.
Cognosos Weekly Intel Updates
Receive weekly intel updates about Cognosos straight to your inbox.
Competitors
Cognosos Competitors
RTLS (Real-Time Location Systems) competitors such as PatientTrak FLOW focus on specific niches like healthcare asset management. PatientTrak FLOW, for instance, offers a solution tailored for patient flow and asset tracking within hospitals, emphasizing ease of integration and user-friendly interfaces (Avia Marketplace). While Cognosos also serves healthcare, its broader market approach and AI capabilities give it a competitive edge in operational intelligence.
Market and consulting firms like Cognosis Consulting provide competitor analysis and strategic insights, helping organizations understand market positioning and identify opportunities for differentiation (Cognosis.co.uk). These firms do not directly compete in RTLS but support strategic decision-making for companies like Cognosos, highlighting the importance of market intelligence in this sector.
Other RTLS providers such as Zebra Technologies and Impinj offer extensive hardware solutions and RFID-based tracking systems. These competitors generally focus on hardware robustness, scalability, and integration with enterprise systems. While they may have larger market shares due to their established presence, Cognosos's AI-driven, lightweight approach offers a more flexible and potentially cost-effective alternative for specific use cases (Tracxn).
In summary, Cognosos's competitive landscape includes specialized RTLS providers like PatientTrak, hardware giants like Zebra, and strategic consulting firms. Its unique value proposition lies in AI-powered insights and lightweight infrastructure, positioning it as a versatile player in the evolving asset tracking market.
Product & Pricing
Cognosos Product and Pricing Intelligence
Recent sources from 2025 highlight that Cognosos operates on a subscription-based service model, with no publicly available free tier or free trial, emphasizing a focus on enterprise clients who require scalable, customizable solutions (saascounter.com, softwaresuggest.com)). The platform’s flexibility and lightweight deployment make it suitable for rapid implementation, and its pricing is likely to vary depending on asset volume, feature set, and deployment complexity, with customers able to request a tailored quote for precise costs.
Sources
Cognosos: Real-Time Location Data & Intelligence
cognosos.com
Cognosos Pricing, Features & More 2025 | SaaSCounter
saascounter.com
Cognosos - Pricing, Features, and Details in 2026
softwaresuggest.com
IBM Analytics & Cognos Consulting Services
senturus.com
Cognosos | Pricing, Features & Reviews
technologycounter.com
Cognosos, Inc. Information
rocketreach.co
Ad Campaigns
Cognosos Ad Campaigns
See the live ads Cognosos is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.
See of Cognosos's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Cognosos Hiring and Layoffs
Recent news highlights Cognosos’s ongoing innovation and market expansion, including acquiring Cox 2M and ranking on the Inc. 5000 list of fastest-growing private companies, which signals a strategic emphasis on growth and technological leadership (Cognosos Blog). There are no publicly reported layoffs, and the company’s hiring patterns—focused on senior and operational roles—indicate a strategy aimed at consolidating its market position and advancing its AI-powered asset tracking solutions (Careers at Cognosos). Overall, Cognosos’s hiring trends and recent leadership appointments suggest a company in a growth phase, emphasizing innovation, operational scaling, and market expansion.
Sources
Careers at Cognosos: Join Our Team - Cognosos
cognosos.com
Cognosos, Inc. Jobs - RevPath
revpath.dealhub.io
Company News - Cognosos
cognosos.com
Cognosos, Inc.
es.linkedin.com
Cognosos Appoints Heath Thompson as Chief Executive Officer to Lead Next Phase of Growth
prnewswire.com
Cognosos Jobs + Careers | Built In
builtin.com
Cognosos, Inc. hiring Senior Director, Revenue Operations in Atlanta, GA | LinkedIn
revpath.dealhub.io
Leadership
Cognosos Management and Leadership Team
The leadership team also includes founders Jim Stratigos and Nish Parikh, who are responsible for setting the strategic direction and fostering innovation within the company (The Org). Recent leadership changes highlight a strategic shift towards scaling the company's location intelligence solutions, with a focus on operational visibility and enterprise growth (Cognosos). The company continues to grow its influence in the asset management and IoT sectors, supported by significant funding and recent acquisitions, such as GearTrack by Cox2M (Cognosos).
Sources
Cognosos, Inc. Management Team | Org Chart - RocketReach
rocketreach.co
Cognosos: Heath Thompson Appointed As Chief Executive ...
pulse2.com
Cognosos Appoints Heath Thompson as Chief Executive Officer to ...
prnewswire.com
About Us - Cognosos
cognosos.com
Leadership Team - Cognosos - The Org
theorg.com
Board of Directors - Cognos Therapeutics
cognosthx.com
Cognosos Appoints Heath Thompson as Chief Executive Officer to Lead Next Phase of Growth | PR Newswire | wfmz.com
wfmz.com
Cognosos, Inc.
es.linkedin.com
Financials
Cognosos Financial Performance, Fundraising, M&A
There is no publicly available information suggesting that Cognosos has undergone any recent mergers or acquisitions, nor are there clear indicators of its current financial health or profitability. The company’s profile suggests it is still in growth or scaling phases, with ongoing investments and strategic development, but precise financial metrics or valuation figures remain undisclosed (Tracxn).
For the most current and detailed financial data, including revenue, fundraising amounts, and valuation, direct company disclosures or recent financial reports would be necessary, which are not available in the current search results.
Partnerships
Cognosos Partnerships, Clients and Vendors
In terms of enterprise clients, while the search results do not specify individual clients, Cognosos's partnerships include collaborations with major industry players such as IBM. The IBM Partner Plus Directory indicates that IBM collaborates with a broad network of business partners, which could include Cognosos or similar companies providing integrated solutions (IBM Partner Plus). This ecosystem relationship highlights Cognosos's role within a larger technological and solutions-based network.
Furthermore, Cognosos's technology integrations and vendor relationships are likely aligned with its acquisitions and strategic growth initiatives, although explicit details are not provided in the search results. The company's focus on expanding its technological footprint through acquisitions suggests a commitment to developing a robust ecosystem of partners, clients, and vendors to enhance its offerings and market presence.
Events
Cognosos Event Participations
While specific details about other conferences, webinars, or community events are not explicitly listed in the search results, Cognosos’s presence at HIMSS26 indicates their active engagement in industry-leading healthcare technology events. Their participation at such prominent gatherings underscores their commitment to advancing healthcare asset management and staff-patient interaction solutions (Cognosos).
Additionally, Cognosos’s innovations, like disposable wristbands and encounter-sensing tags, are often highlighted during these events, emphasizing their role in addressing clinician burnout and improving hospital operational efficiency (BriefGlance). As of March 2026, their focus remains on demonstrating their latest technology at HIMSS, a key platform for healthcare industry networking and innovation showcase.
Sources
Cognosos Unveils Staff-Patient Encounter Sensing Tags
cognosos.com
Cognosos Unveils 'Holy Grail' Tech to Combat Clinician Burnout - BriefGlance.com
briefglance.com
[PDF] Cognos Event Studio - BISP Trainings
bisptrainings.com
Event Studio User Guide - IBM
ibm.com
Cognosos unveils next generation staff-patient encounter-sensing ...
prnewswire.com
Cognosos unveils next generation staff-patient encounter-sensing tags at HIMSS26
finance.yahoo.com
Cognosos Ranks No. 808 in the 2025 Inc. 5000 List
cognosos.com
Frequently Asked Questions
What does Cognosos's hiring of a Senior Director of Revenue Operations signal about where the company is in its growth cycle?
Cognosos is prioritizing commercial scaling over pure product development, which is a classic signal of a company transitioning from early-stage build to a revenue-acceleration phase. The Senior Director of Revenue Operations hire — focused on pipeline efficiency and go-to-market operations — combined with the company ranking No. 808 on the 2025 Inc. 5000 list and the acquisition of GearTrack by Cox 2M, suggests Cognosos is trying to operationalize growth it has already demonstrated, not just fund experimentation. With roughly 79 employees, the weight placed on senior revenue infrastructure roles indicates leadership believes the sales motion needs tightening more than the product does right now.
What does the appointment of Heath Thompson as CEO signal about Cognosos's strategic direction?
The appointment of Heath Thompson as CEO signals a deliberate pivot toward enterprise scaling and multi-sector expansion, replacing a founder-led growth model with experienced executive leadership. Thompson was brought in explicitly to lead the company's 'next phase of growth,' which in context means broadening the AI-powered location intelligence platform across automotive logistics, healthcare, and industrial operations simultaneously. This type of leadership transition — from founding team to outside operator — typically precedes a significant fundraise, an acquisition push, or preparation for a liquidity event, though no such event has been publicly announced.
How should a corp-dev team interpret Cognosos's acquisition of GearTrack by Cox 2M?
The Cox 2M acquisition is a capability and customer-base consolidation play, not a diversification bet — Cox 2M's GearTrack product strengthens Cognosos's position in automotive logistics and yard management, which is one of its core verticals alongside healthcare. For a company of roughly 79 employees, absorbing an acquisition signals confidence in operational capacity and suggests Cognosos is willing to use M&A to accelerate vertical depth rather than waiting to build organically. Corp-dev teams evaluating Cognosos as an acquirer or target should note that this pattern, combined with Inc. 5000 placement and new CEO hire, suggests the company is in an active consolidation window.
What does Cognosos's decision to unveil encounter-sensing tags at HIMSS26 — rather than a more general IoT or supply chain event — tell us about its vertical prioritization?
Choosing HIMSS26 as the launch venue for next-generation staff-patient encounter-sensing tags signals that healthcare has become Cognosos's highest-profile vertical for product innovation, even as the company serves automotive and logistics. The encounter-sensing use case — improving clinical documentation and combating clinician burnout — is a higher-acuity, higher-differentiation problem than generic asset tracking, which means Cognosos is competing for clinical workflow budgets, not just facilities or supply-chain budgets. This positioning targets hospital decision-makers at the C-suite and CMO level, which typically means longer sales cycles but larger and stickier contracts.
Is Cognosos's financial trajectory readable from public signals, and what do those signals suggest about runway and funding stage?
Precise revenue figures and funding amounts are not publicly disclosed, which is consistent with a private company managing competitive information carefully. However, the available signals — Inc. 5000 ranking at No. 808 in 2025, active acquisition activity, a new CEO hire, and ongoing enterprise customer deployments — collectively suggest a company generating meaningful recurring revenue and not in distress. The absence of any disclosed fundraising round amounts makes it difficult to assess runway or valuation directly; analysts should treat Cognosos as likely Series B-equivalent in maturity based on headcount (~79), acquisition activity, and growth ranking, but that inference requires verification through direct engagement.
How does Cognosos's lightweight-infrastructure, AI-first approach differentiate it competitively against hardware-heavy RTLS incumbents like Zebra Technologies?
Cognosos's core competitive wedge against incumbents like Zebra Technologies and Impinj is reducing the infrastructure burden that has historically made enterprise RTLS deployments expensive and slow to scale. By using AI and machine learning to derive high-accuracy location data from minimal hardware — leveraging Bluetooth and GPS rather than dense reader networks — Cognosos can offer faster deployment and lower upfront costs, which is a meaningful advantage when selling to mid-sized healthcare systems or automotive facilities that cannot justify a Zebra-scale infrastructure investment. The risk for Cognosos is that Zebra's entrenched enterprise relationships and hardware ecosystem create high switching costs, making greenfield deployments and verticals underserved by legacy providers the more realistic near-term battleground.
What does Cognosos's subscription-only, quote-based pricing model reveal about its target buyer profile and deal structure?
The absence of a published price list or free tier, combined with a quote-based subscription model, is a deliberate signal that Cognosos is selling exclusively to enterprises with complex deployment requirements — not SMBs or self-serve buyers. This model allows pricing to flex with asset volume, feature set, and deployment complexity, which is appropriate for healthcare systems and automotive manufacturers where contract values can vary by orders of magnitude. The lack of a free trial also reflects a high-touch, consultative sales motion, consistent with the company's investment in a Senior Director of Revenue Operations and its focus on ROI delivery within months as a key customer value proposition.
What does Cognosos's dual-vertical focus on healthcare and automotive logistics imply about competitive risk and strategic coherence?
Operating simultaneously in healthcare RTLS and automotive yard management creates real portfolio coherence risk — the buyer personas, procurement cycles, regulatory environments, and integration requirements in these verticals are almost entirely distinct. The strategic logic appears to be that Cognosos's AI-driven location platform is genuinely horizontal, with the vertical differentiation coming from application layer and hardware form factor rather than core technology. The Cox 2M acquisition deepened automotive capabilities while HIMSS26 product launches deepened healthcare, suggesting Cognosos is consciously investing in both rather than consolidating around one — which is a credible but capital-intensive strategy that becomes more vulnerable if a well-funded single-vertical competitor accelerates.
What do Cognosos's Inc. 5000 ranking and M&A activity together suggest about its growth mechanism — organic vs. inorganic?
Ranking No. 808 on the 2025 Inc. 5000 indicates strong organic revenue growth over the prior three-year measurement window, since the Inc. 5000 methodology is based on revenue growth not adjusted for acquisitions at the time of ranking. The Cox 2M GearTrack acquisition then adds an inorganic layer on top of that organic base, which means Cognosos's forward growth rate could be higher than the Inc. 5000 trajectory suggests, but also carries integration execution risk. For a company of 79 employees, managing simultaneous organic growth across two major verticals while integrating an acquisition is an operationally demanding combination — the Revenue Operations hire likely reflects awareness of that tension.
Does Cognosos have a credible enterprise partnership ecosystem, or is it still a standalone point solution?
The publicly available evidence on formal partnerships is thin — there is a reference to IBM's partner ecosystem that may or may not include Cognosos directly, and no named channel or reseller partnerships are confirmed in available disclosures. This suggests Cognosos is still largely selling direct, which is consistent with its quote-based, high-touch sales model and sub-100-person headcount. For a corp-dev or competitive-intelligence analyst, the absence of a visible partner ecosystem is both a vulnerability — limiting distribution scale — and an opportunity signal, as a strategic acquirer or large platform player could add significant value by plugging Cognosos's technology into an established channel.
How should a healthcare technology strategist interpret Cognosos's encounter-sensing tag product relative to the clinician burnout problem it claims to address?
Cognosos is positioning encounter-sensing tags as a clinical documentation automation play, not just an asset tracking upgrade — the tags are designed to automatically capture staff-patient interactions, reducing the manual charting burden that is a documented driver of clinician burnout. This is a materially higher-value proposition than traditional RTLS asset location because it connects to clinical quality metrics and physician satisfaction scores that hospital C-suites actively track and fund. If the product delivers on accurate encounter detection without workflow disruption, it competes indirectly with ambient AI documentation tools like Nuance DAX or Suki, though via a hardware-sensing approach rather than voice AI — a differentiated but unproven-at-scale method as of early 2026.
With a new CEO, a recent acquisition, and a major product launch at HIMSS26 all occurring within roughly the same window, what is the most plausible near-term strategic scenario for Cognosos?
The convergence of a CEO transition, inorganic expansion via Cox 2M, and a flagship product launch at HIMSS26 within a compressed timeframe is a strong signal of deliberate preparation for a step-change event — most likely a significant Series B or growth equity raise, a strategic partnership with a large healthcare IT or logistics platform, or positioning for acquisition. Companies of Cognosos's size and stage rarely execute all three of those moves simultaneously without a specific near-term objective in mind. The most plausible read is that incoming CEO Heath Thompson is building the narrative and operational infrastructure needed to attract either institutional capital or a strategic buyer within an 18-to-24-month window, though no transaction has been announced.
Powered by ForesightIQ · Competitive intelligence from digital exhaust